NCT04955327View on ClinicalTrials.gov

To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

March 20, 2021

Primary Completion Date

February 25, 2022

Study Completion Date

February 25, 2022

Conditions
Upper Respiratory Tract Infection
Interventions
DRUG

A. Paniculata

Extract from A. Paniculata

DRUG

A. Chilensis

Extract from A. Chilensis

DRUG

A. Paniculata and A. Chilensis

Combination of A. Paniculata and A. Chilensis

DRUG

Microcrystalline cellulose

Placebo comparator

Trial Locations (5)

208001

Apollo Spectra Hospitals, Kanpur

221005

Shubham Sudbhawana Super Specialty Hospital, Varanasi

400001

St . George Hospital, Mumbai

440009

Gillurkar Multispecialty Hospital, Nagpur

Shree Hospital & Critical Care Center, Nagpur

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT04955327 - To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI | Biotech Hunter | Biotech Hunter